187 related articles for article (PubMed ID: 31481982)
1. Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.
Jiang X; Bai XY; Li B; Li Y; Xia K; Wang M; Li S; Wu H
Dis Markers; 2019; 2019():5069614. PubMed ID: 31481982
[TBL] [Abstract][Full Text] [Related]
2. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
3. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
5. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
6. ITIH4 is a novel serum biomarker for early gastric cancer diagnosis.
Sun Y; Jin J; Jing H; Lu Y; Zhu Q; Shu C; Zhang Q; Jing D
Clin Chim Acta; 2021 Dec; 523():365-373. PubMed ID: 34687700
[TBL] [Abstract][Full Text] [Related]
7. Human inter-alpha-trypsin inhibitor heavy chain H3 gene. Genomic organization, promoter analysis, and gene linkage.
Diarra-Mehrpour M; Sarafan N; Bourguignon J; Bonnet F; Bost F; Martin JP
J Biol Chem; 1998 Oct; 273(41):26809-19. PubMed ID: 9756925
[TBL] [Abstract][Full Text] [Related]
8. ITIH3 and ITIH4 polymorphisms and depressive symptoms during pregnancy in Japan: the Kyushu Okinawa Maternal and Child Health Study.
Miyake Y; Tanaka K; Arakawa M
J Neural Transm (Vienna); 2018 Oct; 125(10):1503-1509. PubMed ID: 29992445
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal change of serum inter-alpha-trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis.
Zhao X; Guo Y; Li L; Li Y
J Clin Lab Anal; 2023 Feb; 37(3):e24834. PubMed ID: 36725250
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Change of Serum Inter-α-Trypsin Inhibitor Heavy Chain H4 and its Relation with Inflammation, Disease Recurrence, and Mortality in Acute Ischemic Stroke Patients.
Zhang J; Hu J; Zhao W
Tohoku J Exp Med; 2023 Feb; 259(3):221-227. PubMed ID: 36596502
[TBL] [Abstract][Full Text] [Related]
11. Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Osada A; Matsumoto I; Mikami N; Ohyama A; Kurata I; Kondo Y; Tsuboi H; Ishigami A; Sano Y; Arai T; Ise N; Sumida T
Clin Exp Immunol; 2021 Mar; 203(3):385-399. PubMed ID: 33238047
[TBL] [Abstract][Full Text] [Related]
12. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract][Full Text] [Related]
13. ITIH4, as an inflammation biomarker, mainly increases in bacterial bloodstream infection.
Ma Y; Li R; Wang J; Jiang W; Yuan X; Cui J; Wang C
Cytokine; 2021 Feb; 138():155377. PubMed ID: 33348064
[TBL] [Abstract][Full Text] [Related]
14. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
Meng C; Yin X; Liu J; Tang K; Tang H; Liao J
PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Mroczko B; Groblewska M; Okulczyk B; Kedra B; Szmitkowski M
Int J Colorectal Dis; 2010 Oct; 25(10):1177-84. PubMed ID: 20556397
[TBL] [Abstract][Full Text] [Related]
16. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
17. Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.
He K; He S; Su M
J Clin Lab Anal; 2022 Mar; 36(3):e24231. PubMed ID: 35064701
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an ELISA for the quantification of bovine ITIH4 in serum and milk.
Soler L; García N; Andrés M; Armengol R; Lampreave F; Alava MA; Piñeiro M
Vet Immunol Immunopathol; 2019 Nov; 217():109922. PubMed ID: 31450165
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
[TBL] [Abstract][Full Text] [Related]
20. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
